Nevakar Inc.

Nevakar Inc. company information, Employees & Contact Information

Updated May 2026

Quick answer

Nevakar Inc. is a Pharmaceutical Manufacturing company and founded in 2015. It has approximately 34 employees on record. Contact data was last refreshed in May 2026. Find Nevakar Inc.'s verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

Repositioning Drugs for a Better Outcome. Nevakar is a specialty injectable pharmaceutical company, focused on developing innovative products in injectable and ophthalmic space. Our goal is to develop enhanced products that address unmet clinical and/or commercial needs of currently [FDA] approved molecules, through intensive R&D and clinical efforts.

Company Details

Employees
34
Founded
2015
Address
1019 Route Us Highway 202/206,
Phone
(908)367-7400
Email
in****@****kar.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Bridgewater, New Jersey
Looking for a particular Nevakar Inc. employee's phone or email?

Nevakar Inc. Questions

News

Nevakar Inc. Announces Formation Of Nevakar Injectables - PR Newswire

Nevakar Inc. Announces Formation Of Nevakar Injectables PR Newswire

Long Grove Pharmaceuticals Secures Commercial Rights to an Essential Critical Care Medication - BioSpace

Long Grove Pharmaceuticals Secures Commercial Rights to an Essential Critical Care Medication BioSpace

Nevakar Announces Formation Of Ophthalmic Company, Vyluma - PR Newswire

Nevakar Announces Formation Of Ophthalmic Company, Vyluma PR Newswire

Baxter Wins Some Relief on Nevakar Blood-Pressure Drug Patents - Bloomberg Law News

Baxter Wins Some Relief on Nevakar Blood-Pressure Drug Patents Bloomberg Law News

Ready-to-Dilute Cyclophosphamide Injections Obtain FDA Approval - Oncology Nursing News

Ready-to-Dilute Cyclophosphamide Injections Obtain FDA Approval Oncology Nursing News

Théa inks $135M deal for EU rights to Nevakar's myopia eye drops - Fierce Pharma

Théa inks $135M deal for EU rights to Nevakar's myopia eye drops Fierce Pharma

Nevakar Injectables can proceed with equivalents theory against Baxter, US judge says - MLex

Nevakar Injectables can proceed with equivalents theory against Baxter, US judge says MLex

Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Nevakar - PR Newswire

Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Nevakar PR Newswire

Themis Medicare signs agreement with Nevakar for injectable products - Equitypandit

Themis Medicare signs agreement with Nevakar for injectable products Equitypandit

MyMyopia™ Introduces Infographic for Easy Understanding of Myopia, its Impact, and Treatment Options - PR Newswire

MyMyopia™ Introduces Infographic for Easy Understanding of Myopia, its Impact, and Treatment Options PR Newswire

Top Nevakar Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant